Mirtazapine and Ingrowing nail - a phase IV clinical study of FDA data

Summary:

Ingrowing nail is reported as a side effect among people who take Mirtazapine (mirtazapine), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Alprazolam, and have Breast cancer.

The phase IV clinical study analyzes which people have Ingrowing nail when taking Mirtazapine. It is created by eHealthMe based on reports of 79,492 people who have side effects when taking Mirtazapine from the FDA, and is updated regularly.

What is Mirtazapine?

Mirtazapine has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 82,120 Mirtazapine users. Check the latest studies of Mirtazapine.

What is Ingrowing nail?

Ingrowing nail is found to be associated with 540 drugs and 408 conditions by eHealthMe. Check the latest studies of Ingrowing nail.

On Jul, 09, 2026

79,492 people reported to have side effects when taking Mirtazapine.
Among them, 35 people (0.04%) have Ingrowing nail.

Among these 35 people:

How long have people been on Mirtazapine when they have Ingrowing nail? *

What is the gender of people who have Ingrowing nail when taking Mirtazapine? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Ingrowing nail when taking Mirtazapine? *

What are other drugs people take besides Mirtazapine? *

What are other side effects people have besides Ingrowing nail? *

Urinary Tract Infection: 26 people, 74.29%
Memory Loss: 26 people, 74.29%
Joint Pain: 25 people, 71.43%
Hypoaesthesia (reduced sense of touch or sensation): 24 people, 68.57%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 24 people, 68.57%
Pain In Extremity: 24 people, 68.57%
Spinal Osteoarthritis (joint cartilage loss in spine): 24 people, 68.57%
Posture Abnormal: 23 people, 65.71%
Injury: 23 people, 65.71%
Physical Disability: 23 people, 65.71%

What are the existing conditions these people have? *

Hypercalcaemia (elevated calcium (ca+) level in the blood): 23 people, 65.71%
Breast Cancer: 23 people, 65.71%
Breast Cancer Metastatic: 22 people, 62.86%
Immunodeficiency Common Variable: 5 people, 14.29%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 5.71%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 5.71%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 5.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.86%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.86%
Migraine (headache): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Mirtazapine and have Ingrowing nail?

- Check whether Ingrowing nail is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mirtazapine:

Mirtazapine (82,120 reports)

Ingrowing nail treatments and more:

Ingrowing nail (3,607 reports)

Browse all side effects of Mirtazapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ingrowing nail:

Ingrowing nail (540 drugs)

Browse all the conditions that are associated with Ingrowing nail:

Ingrowing nail (408 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine (the active ingredients of Mirtazapine) and Mirtazapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.